Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...

Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...

Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and ...

The devices have surged in popularity among people without diabetes, but a study suggests reality may not match the hype.View on euronews ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The company's CEO, Tom Hale, told MobiHealthNews Oura will use the funds "for AI-driven innovation to redefine what digital ...

Spending more time in glucose range could help reduce adverse pregnancy outcomes, but available closed-loop insulin delivery systems are not customized to pregnancy-specific needs. In a randomized ...

Health Panels follows the lead of competitors by offering blood tests that users can schedule and review within the Oura app.

Research shows that more daytime movement in pregnant women with hyperglycemia can raise nighttime blood sugar, highlighting ...

The Flinn Foundation recently released the latest version of its Bioscience Roadmap for Arizona — a guide to the sector in ...

Oura's chief commercial officer doesn't seem particularly worried about capturing every demographic. Instead, she's focused ...

Walmart will become the first U.S. retailer to sell an over-the-counter continuous glucose monitor in physical stores, as ...